Cal-Maine Foods Reports Steep Q3 Earnings Decline, Announces Major Acquisition & New Avian Flu Outbreak
summarizeSummary
Cal-Maine Foods reported a sharp Q3 earnings decline year-over-year but beat analyst estimates, while also disclosing a significant post-quarter acquisition and a new avian flu outbreak.
check_boxKey Events
-
Q3 2026 Financial Results
Net sales for the third quarter decreased 53.0% year-over-year to $667.0 million, and net income attributable to Cal-Maine Foods, Inc. plummeted 90.1% to $50.5 million ($1.07 per basic share). These results, however, surpassed analyst estimates of $642.48 million revenue and $0.70 EPS.
-
Significant Post-Quarter Acquisition
Effective March 2, 2026, the company acquired the shell egg, egg products, and prepared foods assets of Creighton Brothers LLC and Crystal Lake LLC for approximately $128.5 million, adding 3.2 million layers and processing facilities.
-
New HPAI Outbreak Reported
A highly pathogenic avian influenza (HPAI) outbreak occurred at a Maryland pullet facility on March 14, 2026, resulting in the depopulation of approximately 350,000 pullets.
-
Active Share Repurchase Program
The company repurchased $101.0 million of common stock under its $500 million share repurchase program during the thirty-nine weeks ended February 28, 2026, with $350.8 million remaining authorization.
auto_awesomeAnalysis
Cal-Maine Foods reported a significant year-over-year decline in its third-quarter financial results, with net sales down 53% and net income down 90%. This substantial drop was primarily driven by lower shell egg prices. However, the company's reported EPS of $1.07 and revenue of $667.0 million both surpassed recent analyst estimates, suggesting the market may have anticipated even worse performance. Strategically, the company announced a significant post-quarter acquisition of Creighton Brothers LLC for $128.5 million, expanding its production capacity and prepared foods offerings. This positive strategic move is counterbalanced by a new highly pathogenic avian influenza (HPAI) outbreak at a Maryland facility, resulting in the depopulation of 350,000 pullets, which introduces fresh operational risk. Investors should monitor the impact of the HPAI outbreak on future supply and pricing, as well as the integration and benefits of the new acquisition.
At the time of this filing, CALM was trading at $80.89 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.8B. The 52-week trading range was $71.92 to $126.40. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.